ConductScience.org, home

Paper30177832

Heterogeneous cancer-associated fibroblast population potentiates neuroendocrine differentiation and castrate resistance in a CD105-dependent manner.

Kato M and 14 others. Oncogene, 2019. Cited by 77 papers, by iCite.

Cite this record

ConductScience Library. Heterogeneous cancer-associated fibroblast population potentiates neuroendocrine differentiation and castrate resistance in a CD105-dependent manner. Papers, record 30177832. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/30177832

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Heterogeneous cancer-associated fibroblast population potentiates neuroendocrine differentiation and castrate resistance in a CD105-dependent manner.
PubMed
Journal
Oncogene
PubMed
Year
2019
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural, Research Support, U.S. Gov't, Non-P.H.S.
PubMed
Citations, by iCite
77
iCite
Relative citation ratio, by iCite
2.69
iCite
Revised in PubMed
2020-04-25
PubMed

Authors15

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Kato MManabu
2Placencio-Hickok VRVeronica R
3Madhav AAnisha
4Haldar SSubhashhttps://orcid.org/0000-0002-1230-1770
5Tripathi MManisha
6Billet SSandrine
7Mishra RRajeev
8Smith BBethany
9Rohena-Rivera KKrizia
10Agarwal PPriyanka
11Duong FFrank
12Angara BBryan
13Hickok DDavid
14Liu ZZhenqiu
15Bhowmick NANeil A

Source PubMed

Download CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Cell DifferentiationMajor topic
EndoglinMajor topic
FibroblastsMajor topic
Neoplasm ProteinsMajor topic
Neuroendocrine CellsMajor topic
Prostatic Neoplasms, Castration-ResistantMajor topic
Signal TransductionMajor topic
Cell Line, Tumor
Humans
Male

Source PubMed

Download CSV of topics

Grants9

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
T32 DK007770NIDDK NIH HHSUnited StatesT32DK007770PubMed and NIHNIH RePORTER
CA108646U.S. Department of Health & Human Services | NIH | National Cancer Institute (NCI)InternationalR01CA108646PubMed and NIHNIH RePORTER
P01 CA098912NCI NIH HHSUnited StatesP01CA098912PubMed and NIHNIH RePORTER
BX001040U.S. Department of Veterans Affairs (VA)InternationalI01BX001040PubMed and NIHNIH RePORTER
PC160946U.S. Department of Defense (DOD)InternationalPubMedPubMed
CA098912U.S. Department of Health & Human Services | NIH | National Cancer Institute (NCI)InternationalP01CA098912PubMed and NIHNIH RePORTER
R01 CA108646NCI NIH HHSUnited StatesR01CA108646PubMed and NIHNIH RePORTER
I01 BX001040BLRD VAUnited StatesI01BX001040PubMed and NIHNIH RePORTER
PC161016U.S. Department of Defense (DOD)InternationalPubMedPubMed

Download CSV of grants

References48

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
127207661Icaritin suppresses development of neuroendocrine differentiation of prostate cancer through inhibition of IL-6/STAT3 and Aurora kinase A pathways in TRAMP mice.Carcinogenesis2016https://conductscience.org/library/papers/27207661PubMed
225956356Zodiac: A Comprehensive Depiction of Genetic Interactions in Cancer by Integrating TCGA Data.J Natl Cancer Inst2015https://conductscience.org/library/papers/25956356PubMed
328740046INITIAL EXPERIENCE OF THE ENZALUTAMIDE TREATMENT FOR CASTRATION-RESISTANT PROSTATE CANCER.Nihon Hinyokika Gakkai Zasshi2016https://conductscience.org/library/papers/28740046PubMed
425307287Pathological significance and prognostic role of microvessel density, evaluated using CD31, CD34, and CD105 in prostate cancer patients after radical prostatectomy with neoadjuvant therapy.Prostate2015https://conductscience.org/library/papers/25307287PubMed
524881730Enzalutamide in metastatic prostate cancer before chemotherapy.N Engl J Med2014https://conductscience.org/library/papers/24881730PubMed
618371946Secreted frizzled related protein 1 is a paracrine modulator of epithelial branching morphogenesis, proliferation, and secretory gene expression in the prostate.Dev Biol2008https://conductscience.org/library/papers/18371946PubMed
721673995The role of calcineurin/NFAT in SFRP2 induced angiogenesis--a rationale for breast cancer treatment with the calcineurin inhibitor tacrolimus.PLoS One2011https://conductscience.org/library/papers/21673995PubMed
825407442A phase I study of TRC105 anti-endoglin (CD105) antibody in metastatic castration-resistant prostate cancer.BJU Int2015https://conductscience.org/library/papers/25407442PubMed
923518348The E3 ubiquitin ligase Siah2 contributes to castration-resistant prostate cancer by regulation of androgen receptor transcriptional activity.Cancer Cell2013https://conductscience.org/library/papers/23518348PubMed
1028905415Hyperactive mTOR induces neuroendocrine differentiation in prostate cancer cell with concurrent up-regulation of IRF1.Prostate2017https://conductscience.org/library/papers/28905415PubMed
1123826159Discovery and validation of a prostate cancer genomic classifier that predicts early metastasis following radical prostatectomy.PLoS One2013https://conductscience.org/library/papers/23826159PubMed
1216288033Identification of SFRP1 as a candidate mediator of stromal-to-epithelial signaling in prostate cancer.Cancer Res2005https://conductscience.org/library/papers/16288033PubMed
1323728425The perivascular niche regulates breast tumour dormancy.Nat Cell Biol2013https://conductscience.org/library/papers/23728425PubMed
1421863023Upregulation of cancer-associated myofibroblasts by TGF-β from scirrhous gastric carcinoma cells.Br J Cancer2011https://conductscience.org/library/papers/21863023PubMed
1528620903Emerging Categories of Disease in Advanced Prostate Cancer and Their Therapeutic Implications.Oncology (Williston Park)2017https://conductscience.org/library/papers/28620903PubMed
1629112233Neuroendocrine tumors and fibrosis: An unsolved mystery?Cancer2017https://conductscience.org/library/papers/29112233PubMed
171712249Acceleration of human prostate cancer growth in vivo by factors produced by prostate and bone fibroblasts.Cancer Res1991https://conductscience.org/library/papers/1712249PubMed
1825719802Diagnostic value of SFRP1 as a favorable predictive and prognostic biomarker in patients with prostate cancer.PLoS One2015https://conductscience.org/library/papers/25719802PubMed
1916258976The molecular genetics of gastroenteropancreatic neuroendocrine tumors.Cancer2005https://conductscience.org/library/papers/16258976PubMed
2027487144Molecular mechanisms underlying resistance to androgen deprivation therapy in prostate cancer.Oncotarget2016https://conductscience.org/library/papers/27487144PubMed

See all 48 referencesDownload CSV of references

Cited by68

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 77 citations.

PMIDTitleJournalYearIn PapersSource
42694990The Role of Distinct Cancer-Associated Fibroblast Subtypes in Prostate Cancer Immunotherapy.Int J Biol Sci2026https://conductscience.org/library/papers/42694990PubMed
42518286Local growth hormone promotes benign prostatic hyperplasia.JCI Insight2026https://conductscience.org/library/papers/42518286PubMed
42276991CAF-derived PTGDS drives pancreatic cancer neuroendocrine differentiation and chemoresistance via PAQR9-MAPK.Oncogenesis2026https://conductscience.org/library/papers/42276991PubMed
41689691Neuroendocrine prostate cancer (NEPC) in focus: state of the art and future prospectives.Discov Oncol2026https://conductscience.org/library/papers/41689691PubMed
41378308Optimised dissociation and multimodal profiling of prostate cancer stroma reveal fibromuscular cell heterogeneity with clinical correlates.Front Cell Dev Biol2025https://conductscience.org/library/papers/41378308PubMed
41327620A Metastasis-competent CAF Subpopulation Defined by MFAP5⁺THY1⁺ Co-expression Drives Prostate Cancer Metastasis via EMT Activation.Recent Pat Anticancer Drug Discov2026https://conductscience.org/library/papers/41327620PubMed
41327318Unraveling the YAP1-TGFβ1 axis: a key driver of androgen receptor loss in prostate cancer-associated fibroblasts.J Exp Clin Cancer Res2025https://conductscience.org/library/papers/41327318PubMed
41136557Cytokine CCL2 secreted by cancer-associated fibroblasts augments temozolomide resistance in glioblastoma through ERK1/2 signaling.Oncogene2025https://conductscience.org/library/papers/41136557PubMed
40917018Enzalutamide-Resistant STEAP4+ MyoCAF Secrete Phosphatidylcholine to Foster Progression by Activating Stemness in Hormone-Sensitive Prostate Cancer.Adv Sci (Weinh)2025https://conductscience.org/library/papers/40917018PubMed
40644310Endoglin mediates the tumor- and metastasis-promoting traits of stromal myofibroblasts in human breast carcinomas.Mol Oncol2025https://conductscience.org/library/papers/40644310PubMed
40499539CXCR4-LASP1-G9a-SNAIL axis drives NEPC transdifferentiation via induction of EMT and downregulation of REST.Cell Genom2025https://conductscience.org/library/papers/40499539PubMed
40375322CD105+ fibroblasts support an immunosuppressive niche in women at high risk of breast cancer initiation.Breast Cancer Res2025https://conductscience.org/library/papers/40375322PubMed
40293223A Cyanobacteria-Derived RNA Aptamer Resensitizes Prostate Cancer to Hormone Therapy.Cancer Res2025https://conductscience.org/library/papers/40293223PubMed
40097577The fibroinflammatory response in cancer.Nat Rev Cancer2025https://conductscience.org/library/papers/40097577PubMed
39335188Evidence of the Link between Stroma Remodeling and Prostate Cancer Prognosis.Cancers (Basel)2024https://conductscience.org/library/papers/39335188PubMed
39300373SFRP1 mediates cancer-associated fibroblasts to suppress cancer cell proliferation and migration in head and neck squamous cell carcinoma.BMC Cancer2024https://conductscience.org/library/papers/39300373PubMed
38708176Evolving Tumor Characteristics and Smart Nanodrugs for Tumor Immunotherapy.Int J Nanomedicine2024https://conductscience.org/library/papers/38708176PubMed
38335292Stromal-derived MAOB promotes prostate cancer growth and progression.Sci Adv2024https://conductscience.org/library/papers/38335292PubMed
38078010Poly I:C-priming of adipose-derived mesenchymal stromal cells promotes a pro-tumorigenic phenotype in an immunocompetent mouse model of prostate cancer.Front Cell Dev Biol2023https://conductscience.org/library/papers/38078010PubMed
38070051Single-cell analysis extracted CAFs-related genes to established online app to predict clinical outcome and radiotherapy prognosis of prostate cancer.Clin Transl Oncol2024https://conductscience.org/library/papers/38070051PubMed

See all 68 cited byDownload CSV of cited by

Genes39

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ANXA5308PubTator's text mininghttps://conductscience.org/library/genes/308NCBI Gene
AR367PubTator's text mininghttps://conductscience.org/library/genes/367NCBI Gene
AURKA6790PubTator's text mininghttps://conductscience.org/library/genes/6790NCBI Gene
BMP1649PubTator's text mininghttps://conductscience.org/library/genes/649NCBI Gene
BMP2650PubTator's text mininghttps://conductscience.org/library/genes/650NCBI Gene
CHGA1113PubTator's text mininghttps://conductscience.org/library/genes/1113NCBI Gene
CHGB1114PubTator's text mininghttps://conductscience.org/library/genes/1114NCBI Gene
ENG2022PubTator's text mininghttps://conductscience.org/library/genes/2022NCBI Gene
ENO22026PubTator's text mininghttps://conductscience.org/library/genes/2026NCBI Gene
EPCAM4072PubTator's text mininghttps://conductscience.org/library/genes/4072NCBI Gene
EPDR154749PubTator's text mininghttps://conductscience.org/library/genes/54749NCBI Gene
FAP2191PubTator's text mininghttps://conductscience.org/library/genes/2191NCBI Gene
FOXA23170PubTator's text mininghttps://conductscience.org/library/genes/3170NCBI Gene
FST10468PubTator's text mininghttps://conductscience.org/library/genes/10468NCBI Gene
IGF13479PubTator's text mininghttps://conductscience.org/library/genes/3479NCBI Gene
IGFBP23485PubTator's text mininghttps://conductscience.org/library/genes/3485NCBI Gene
IL63569PubTator's text mininghttps://conductscience.org/library/genes/3569NCBI Gene
KIT3815PubTator's text mininghttps://conductscience.org/library/genes/3815NCBI Gene
KLK3354PubTator's text mininghttps://conductscience.org/library/genes/354NCBI Gene
LOX4015PubTator's text mininghttps://conductscience.org/library/genes/4015NCBI Gene

See all 39 genesDownload CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/30177832

GET https://conductscience.org/api/papers/v1/30177832/references?page=2